Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (16)

2023

  1. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy

    Frontiers in Immunology, Vol. 14

2016

  1. Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives

    Critical Reviews in Oncology/Hematology, Vol. 107, pp. 54-71

2012

  1. Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target

    International Journal of Radiation Oncology Biology Physics, Vol. 84, Núm. 5, pp. 1151-1158

2011

  1. A combined strategy of SAGE and quantitative PCR provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer

    Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4145-4154

  2. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy

    Colorectal Disease, Vol. 13, Núm. 9, pp. 989-998

2009

  1. Angiogenesis and ovarian cancer

    Clinical and Translational Oncology, Vol. 11, Núm. 9, pp. 564-571

  2. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: Multicenter phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 63, Núm. 3, pp. 403-409

  3. Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy

    International Journal of Colorectal Disease, Vol. 24, Núm. 7, pp. 741-748

2007

  1. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study

    Lancet Oncology, Vol. 8, Núm. 10, pp. 889-897

  2. Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma

    Free Radical Research, Vol. 41, Núm. 6, pp. 681-687

2006

  1. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

    British Journal of Cancer, Vol. 94, Núm. 7, pp. 969-975

2005

  1. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis

    Carcinogenesis, Vol. 26, Núm. 12, pp. 2095-2104

2004

  1. Do β-tubulin pseudogenes really matter?

    Lancet Oncology

  2. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain)

    Cancer Causes and Control, Vol. 15, Núm. 7, pp. 707-719

2003

  1. New insights in β-tubulin sequence analysis in non-small cell lung cancer

    Lung Cancer, Vol. 41, Núm. 1, pp. 41-48

2002

  1. Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma [3] (multiple letters)

    Cancer